The researchers concluded that risk for MCI was associated with neurodegeneration and neuropsychiatric symptoms among adults aged 50 years and older, and that an abnormal FDG-PET was a stronger driving force for cognitive decline.
The FDA has granted Breakthrough Therapy designation to AXS-05 (Axsome Therapeutics) for the treatment of Alzheimer disease (AD) agitation.
Risk for developing Alzheimer dementia showed the greatest increase among dementia types
Elderly patients with hip fracture have an increased risk for suicide.
The majority of older adults in the sample did not report any depression, anxiety, or stress symptoms, and almost no respondents indicated severe or extremely severe symptoms.
Researchers sought to identify health care system factors that contribute to missed or delayed diagnosis of dementia by primary care providers.
Internet-delivered cognitive behavioral therapy has been shown to reduce anxiety and depression in older adults, and new mobile apps that support self-care and overall mental health may hold promise.
High body weight variability may be associated with increased risk for all-cause dementia and Alzheimer dementia in older patients.
Exposure to air pollution may have adverse effects on cognitive aging and brain health in older adults.
In older women, objectively measured visual impairment is associated with a twofold to more than fivefold increased risk for dementia.
